-
Found on FT.com.
Posted: July 30th, 2009, 4:28pm CEST
Surging sales of cholesterol drug Crestor, combined with the withdrawal of a number of generic competitors from the market, gave AstraZeneca a boost in the second quarter, prompting it to raise its dividend and earnings forecast for the full year...
-
Found on FT.com.
Posted: July 30th, 2009, 3:33pm CEST
Cash-strapped patients who defer medical procedures have depressed sales for some of Smith & Nephew's orthopedic implants, although the medical device group said half-year revenues were stable overall, helped by a new vacuum technology for treating wounds...
-
Found on FT.com.
Posted: July 30th, 2009, 9:04am CEST
The French pharmaceutical group is to buy out joint venture partner Merck's stake in Merial, the animal health business, for $4bn to take full control of the company...
-
Found on FT.com.
Posted: July 30th, 2009, 12:28am CEST
Health minister says it will be up to primary care trusts whether to recommission the treatments centres provide...
-
Found on FT.com.
Posted: July 29th, 2009, 11:10pm CEST
Organic food is no healthier than conventionally produced food, a report published by the Foods Standards Agency has concluded...
-
Found on FT.com.
Posted: July 29th, 2009, 3:07pm CEST
The chief executive of Sanofi-Aventis was warned a surge in demand for the flu vaccine from richer countries could squeeze supply to the developing world...
-
Found on FT.com.
Posted: July 29th, 2009, 1:52pm CEST
French pharmaceutical group aimed to match 2008 sales and income by 2013 as it reported net income up 29 per cent at €2.4bn...
-
Found on FT.com.
Posted: July 28th, 2009, 6:43pm CEST
The Philippines will impose price caps on more than two dozen drug products after an offer by manufacturers to cut prices voluntarily fell short of government expectations...
-
Found on FT.com.
Posted: July 27th, 2009, 11:11pm CEST
Rising commercial medical costs hit second-quarter profits at Aetna, the US health insurer, which reported a 28 per cent in drop in net income and cut its outlook for the year...
-
Found on FT.com.
Posted: July 27th, 2009, 1:46am CEST
Private equity and trade bidders must make sure they have a watertight deal spelling out which partner has control over deciding when to sell and at what price...
-
Found on FT.com.
Posted: July 25th, 2009, 4:00am CEST
Ranbaxy Laboratories, India's largest drugs maker, returned to profit in the quarter to the end of June after three consecutive quarters of loss inflicted by......
-
Found on FT.com.
Posted: July 23rd, 2009, 6:16pm CEST
The threat of the H1N1 flu virus boosted global sales of paper face masks made by Kimberly-Clark, the company said, even as the slump in consumer demand continued to weigh on sales of brands including Huggies and Kleenex...
-
Found on FT.com.
Posted: July 23rd, 2009, 5:00pm CEST
3M, one of the US's biggest diversified manufacturers, saw its second quarter profits fall but the company raised hopes by beating Wall Street estimates on strong sales of healthcare products...
-
Found on FT.com.
Posted: July 23rd, 2009, 3:27pm CEST
Swiss pharmaceuticals company Roche has been helped by a surge in sales on the influenza drug Tamiflu, recording an 13 per cent increase in underlying operating profits...
-
Found on FT.com.
Posted: July 23rd, 2009, 2:16am CEST
US drugmaker Bristol-Myers Squibb Co said it will pay $2.4 billion to acquire Medarex Inc, a biotechnology company that has been helping it develop a promising treatment for melanoma since 2005...
-
Found on FT.com.
Posted: July 22nd, 2009, 8:49pm CEST
GlaxoSmithKline has moved to become the pharmaceuticals company with the broadest range of products to tackle the swine flu pandemic, as it unveiled plans for the sale of masks and diagnostics...
-
Found on FT.com.
Posted: July 22nd, 2009, 8:45pm CEST
The pharmaceutical group was hit by strong competition from generic drugmakers, but saw pockets of strength in consumer healthcare and especially in vaccines...
-
Found on FT.com.
Posted: July 22nd, 2009, 8:08pm CEST
Some pharmas want to tackle the looming patent expiries with pipeline-building deals; others want to glide to safety via cost-driven mergers...
-
Found on FT.com.
Posted: July 22nd, 2009, 5:32pm CEST
Eli Lilly and Pfizer reported higher than estimated earnings, as US pharmaceuticals continued to outperform anaylsts expectations...
-
Found on FT.com.
Posted: July 21st, 2009, 7:27pm CEST
Merck said second-quarter earnings fell as the strengthening dollar, lower vaccine sales and higher taxes bit into its bottom line, but still soundly beat analysts' expectations....
